Auriga maintains a 'Hold' on Thoratec (THOR); Q1 Review
Tweet
Share
E-mailGet Alerts THOR Hot Sheet
Price: $67.99 --0%
Rating Summary:
8 Buy, 16 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 2
Rating Summary:
8 Buy, 16 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 2
Join SI Premium – FREE
Auriga maintains a 'Hold' on Thoratec (NASDAQ: THOR) price target of $35.00.
Auriga analyst said, "Yesterday, Thoratec reported 1Q12 revenue of $127MM (+27%), well both above our $116MM estimate and ahead of the consensus ($112MM) as end market demand was solid in both the U.S. and Europe, due in part to market share gains (Europe), continuing market development efforts and no BTT CAP program for HeartWare during the quarter in the U.S. Given the promising start to the year, THOR increased its 2012 outlook. However, the back half of the year will depend on the timing of HeartWare HVAD approval, which would directly compete with ~30% of THOR's business. Overall, we continue like the potential of THOR's pipeline, however several near term events have been pushed into 2013."
For an analyst ratings summary and ratings history on Thoratec click here. For more ratings news on Thoratec click here.
Shares of Thoratec closed at $34.50 yesterday.
Auriga analyst said, "Yesterday, Thoratec reported 1Q12 revenue of $127MM (+27%), well both above our $116MM estimate and ahead of the consensus ($112MM) as end market demand was solid in both the U.S. and Europe, due in part to market share gains (Europe), continuing market development efforts and no BTT CAP program for HeartWare during the quarter in the U.S. Given the promising start to the year, THOR increased its 2012 outlook. However, the back half of the year will depend on the timing of HeartWare HVAD approval, which would directly compete with ~30% of THOR's business. Overall, we continue like the potential of THOR's pipeline, however several near term events have been pushed into 2013."
For an analyst ratings summary and ratings history on Thoratec click here. For more ratings news on Thoratec click here.
Shares of Thoratec closed at $34.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'
- Evercore ISI Believes Meta Platforms Inc. (META) is Down Due to High Expectations into the Print
- BofA Securities Starts GE Vernova (GEV) at Neutral, 'Multiyear turnaround amid positive demand backdrop'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
AurigaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
